Introduction
Non-alcoholic fatty liver disease (NAFLD) involves abnormal lipid accumulation in the liver and, is related to metabolic syndrome, a combination of medical disorders such as obesity, insulin resistance, type II diabetes, hypertension and hyperlipidemia. The disease can encompass simple lipids in the liver as well as a non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma (1, 2) . Interest in NAFLD has been increased over recent years because of its high prevalence, which resulted from the increase of metabolic syndrome attributed to nutritional imbalances caused by changes in human behavior and lifestyle (3, 4) . However, the causative mechanism of NAFLD are still unknown. According to a previously reported hypothesis, free fatty acids that enter into the liver are oxidized to produce energy or stored as triglycerides from excess free fatty acids. Free fatty acids are the principal contributor to lipoapoptosis and lipotoxicity because they are potential cellular toxins and lead to excessive accumulation of lipid (5) . Furthermore, it has been reported that individual fatty acids have a inherent toxic potential. The toxic effects of free fatty acid are known to depend on their chain length and degree of saturation. In particular, palmitic acid is the most affluent saturated fatty acid in the blood stream and is known to induce cellular dysfunction and cell death in a number of cell types (6, 7) . The lipotoxic effect of palmitate appears predominantly when cells from nonadipose tissues are chronically exposed to high levels of palmitate (8) . Thus, the therapy based on reducing lipid accumulation is ideal for treating the NAFLD because accumulation of neutral lipids (triglycerides) in the liver is the main cause for NAFLD (9) .
Flavonoids are the members of a large class of natural polyphenolic compounds containing in fruits and vegetables regularly consumed by humans (10) . It has been reported that functional phytochemicals such as polyphenols from plants may act as antioxidants to protect against oxidative stress. Given this information, various researches are underway to find natural sources of antioxidants that can be used as therapeutic agents against the pathogenesis of chronic diseases such as cardiovascular, cancer and liver disease (11, 12) .
Citrus fruits, including orange, grapefruit, lemon, lime, mandarin, and tangerine, are rich in flavonoids and contain several kinds of chemopreventive agents such as glycosides and limonoids, hesperidin, glyceroglyclipids, and d-limonene. Citrus unshiu (Satsuma mandarin), a seedless and easy peeled citrus fruit of the Rutaceae family, is a candidate as natural antioxidant source, as well as a variety of bioactive compounds with medicinal properties have been isolated from them. The peel of such fruits has been used as a traditional herbal medicine in east Asia including Korea and China for treating cancer, muscle tension, nausea, dyspepsia, coughs and phlegm, etc (8) . In vitro studies have demonstrated that citrus flavonoids may lower blood cholesterol and triglycerides, as demonstrated in a number of animal studies using rabbits, rat, mice, and hamsters (13) .
Regardless of its physiological properties, a majority of the citrus peel is thrown away causing an environmental problem. Therefore, it is beneficial to find various applications of citrus peel (CP) in many types of processed foods. In this study, we investigated the effects of CP extracts on paimitate-induced steatosis in hepatocytes and the potential mechanisms underlying protective effects. In order to assess this effect, apoptosis-associated signal transduction pathways and expression of apolipoprotein related to intracellular lipid accumulation were assayed.
Meterials and Methods
Preparations of extracts Citrus fruits, which were purchased in a local market located at Jeonju, Korea, were peeled after washing them. Water extracts of CP (CPWE) and ethanol extracts of CP (CPEE) were prepared. Briefly, the CP was dried at room temperature for about 5 days and then blended to make powder. For the CP water extraction, 10 volumes of distilled water were poured into powder, and then heated using an electronic slow boiler for 3 h, followed by filtration and freeze-drying (Ilshin, Yanju, Korea). For the CP ethanol extraction, 10 volumes of 95% ethanol were poured into powder, and then refluxed at 50 o C using a condenser, followed by filtration (Whatman, Little Chalfont, UK) and concentrating using a rotary evaporator (EYELA, Tokyo, Japan). The concentrations of CP extracts were prepared by dissolving 20 mg of extracts in 1 mL of distilled water or 95% ethanol.
Reagents Penicillin G, L-glutamine, tryphan blue, ethanol, Oil Red O, and palmitate were from Sigma-Aldrich (St. Louis, MO, USA). Antibodies against Bcl-2, cytochrome c, caspase-3, apoA1, apo B, and secondary antibodies were procured from Santa Cruz Biotechnology (Santa Cruz, CA, USA). tBid, cleaved caspase-8, 9, b-actin, and Bax antibodies were obtained from Cell Signaling Technology (Beverly, MA, USA). H 2 DCF-DA (2'7'-dichlorodihydrofluorescein diacetate, acetyl ester) was sourced from Invitrogen (Carlsbad, CA, USA).
HPLC analysis HPLC analysis was carried out using a Shimaduzu SCL-10AVP system controller (Shimaduzu, Kyoto, Japan.) with an YMC-Pack ODS-A column (4.6 mmx150 mm I.D., 3 µm particle size, YMC, Kyoto, Japan). The mobile phase was consisted of water/ acetonitrile 77:23 (v/v), the flow rate was 0.7 mL/min, and the separation temperature was 30 o C. The UV detector was set at 280 nm. The injection volume was 10 µL.
Preparation of palmitate/BSA complexes Palmitate was saponified with NaOH after dissolving in ethanol. The sodium salt was dried, resuspended in saline and dissolved at 70 o C. While the solution was still warm, 20% (w/v) BSA was added and the mixture was stirred at room temperature for 4 h to allow palmitate to bind to albumin. The palmitate/BSA complex (6.4 mmol/L fatty acid: 0.8 mmol/L BSA; molar ratio, 7:1) was sterilized by filtering, and aliquoted for future use.
Cell cultures and viability assay HepG2 human hepatocarcinoma cell line was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured with a Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Grand Island, NY, USA) containing penicillin G (100 U/mL), L-glutamine (2 mM), and 10% (v/v) heatinactivated fetal bovine serum (FBS; Gibco BRL) at 37 o C. At 70% confluence, cells were maintained in serum depleted conditions prior to experiments. The HepG2 cells viability assay was performed using tryphan blue staining.
DNA fragmentation assay HepG2 cells were lysed using the lysis buffer [10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, and 0.5% Triton X-100] on ice for 10 min. The lysates were applied to a filter tube using a glass fiber fleece followed by centrifugation (at 12,000×g for 30 min). Residual impurities were removed by washing with PBS (phosphate buffered saline), and subsequently DNA was eluted. Samples were analyzed by electrophoresis on a 1% agarose/ Tris-acetate-EDTA (TAE) gel. After electrophoresis, the gel was stained with ethodium bromide and viewed under ultraviolet light to visualize the DNA bands.
Preparation of the mitochondrial/cytosol fraction Subcellular fractionation was performed using the mitochondria isolation kit (Pierce Biotechnology, Inc., Rockford, IL, USA). Bradford assay (BioRad Laboratories, Hercules, CA, USA) was used to measure proteins in subcellular fractions. Cytochrome c was detected by Western blotting.
Western blot analysis HepG2 cells were lysed in 1% Nonidet P-40, 50 mM HEPES (pH 7.5), 100 mN NaCl, 2 mM EDTA, 1 mM pyrophosphate, 10 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, and 100 mM NaF. The lysates were normalized for analyzing total protein content by using a BCA kit (Pierce Biotechnology, Inc.). Equal amounts of protein were mixed with 2x Laemmli loading buffer and preheated at 95 o C for 5 min. Samples were then electrophorese on 10% SDSpolyacrylamide gels followed by transferring to polyvinylidenedifluoride (PVDF) membrane. The membranes were blocked with 5% skim milk and incubated with primary antibodies. Horseradish peroxidase-conjugated secondary antibodies and enhanced chemiluminescence substrate kit (Pierce Biotechnology, Inc.) were used to detect specific proteins.
Hoechst 33258 staining Morphological changes of cells were assessed by fluorescent microscopy using Hoechst 33258 staining. Fixed cells were stained with Hoechst 33258 (5 µg/mL) at room temperature for 10 min and rinsed, dried, and examined using fluorescence microscope (Olympus, Tokyo, Japan).
Caspase 3 activity assay The activity of caspase-3 was determined using the caspase-3 ELISA kit (BD Pharmingen, San Diego, CA, USA) following the manufacture's protocols. Caspase-3 activity was normalized to cell lysate protein concentration.
Oil red O staining For quantification of intracellular lipid accumulation, the cells were seeded into 24-well plates followed by washing twice with cold PBS and fixed in 3.7% paraformaldehyde for 15 min. Cells were stained with a diluted 0.3% Oil red O solution for 1 h. The excess stain was removed and cells were washed with water. Staining was observed using light microscopy (Olympus).
Determination of total lipid contents The contents of triglyceride (TG) and total cholesterol (TC) were determined enzymatically using commercially available kit (Asan Phamaceutical, Seoul, Korea). Total lipids in cells and medium were extracted and purified using the method described by Bligh and Dyer (11) .
Statistical analysis Data represent the means±standard error (SEM) of at least three separate experiments. Statistical analysis was determined using ANOVA. A value of p<0.05 was considered as significant.
Results and Discussion
Analysis of flavonoids in CP extracts Citrus peels contain high concentration of flavonoids in the forms of flavonone glycosides such as narirutin, naringin, hesperidin, and neohesperidin (14, 15) . These flavonoids are well-known to have health-promoting properties such as antioxidant, anticancer, anti-inflammatory, cardiovascular, and antihyperglycemic activities (16) (17) (18) (19) . Figure 1 shows the HPLC chromatograms of standard flavonoids, CPWE, and CPEE. Narirutin and hesperidin were two major flavonone glycosides detected in both CPWE and CPEE, whereas naringin and neohesperidin were not detected. The amount (36.45±0.34 mg/g) of hesperidin in CPEE was much higher than that (11.32±0.15 mg/g) of CPWE, whereas narirutin contents in CPWE and CPEE were 15.37±0.05 and 15.77±0.02 mg/g, respectively.
Effects of CP extracts on palmitate-induced cytotoxicity in HepG2 cells In the present study, we characterized the effects of CP extracts on in vitro hepatic model of cellular steatosis with lipid overaccumulation profile induced by palmitate. The patients with nonalcoholic fatty liver disease are shown to be increased lipolysis and carried the free fatty acids (FFAs) to the liver. Excessive accumulations of FFAs are associated with more serious liver disease. Many papers have shown that saturated long-chain fatty acids are the major factor of lipotoxicity. The main fatty acids in the human body are palmitic and oleic acids. They are widely used in vitro studies to induce steatosis in cultured human liver cell lines or primary cells as well as steatosis stimulated in vivo (20) .
The potential cytotoxic effect of palmitate or CP extracts in HepG2 cells was first examined. As shown in Fig. 2A , treatment with 250 µM palmitate for 60 h decreased the survival of HepG2 cells which was time-dependently. In contrast, treatment with CPWE or CPEE (10-250 µg/mL) did not affect the cell viability (data not shown). Given these findings, we examined the effects of CP extracts on palmitateinduced cytotoxicity in HepG2 cells. As shown in Fig. 2B and 2C , pretreatment of HepG2 cells with CPWE and CPEE reduced palmitateinduced cytotoxicity in a dose-dependent manner, showing a similar pattern between two CP extracts. Moreover, HepG2 cells pretreated with 100 µg/mL CPWE or CPEE significantly blocked palmitateinduced cell death up to 60 h incubation, while the cell viability of palmitate-induced cells was gradually decreased with time (Fig. 2D) . Based on these results, we chose 100 µg/mL CPWE and CPEE and 250 µM palmitate as the optimal treatment concentration throughout the study.
Effects of CP extracts on palmitate-induced lipid accumulation in HepG2 cells
Palmitate, a saturated long-chain fatty acid, has also been known to induce apoptosis in various cell types (8) , including cardiomycytes, pancreatic b-cells, haematopoietic cells, and astrocytes. Although the mechanism by which palmitate induces cell damage and cell death is not yet fully known, reactive oxygen species (ROS) and cytochrome c have been identified as two major intracellular mediators of palmitate-induced cell death (21, 22) . In this study, we demonstrated the inhibitory effects of CP extracts using in vitro steatosis models of HepG2 cells. In order to investigate the inhibitory effects of CP extracts, the HepG2 cells were treated with the addition of palmitate.
The effect of CP extracts on palmitate-induced lipid accumulation was measured by using Oil Red O staining. As shown in Fig. 3A , lipid droplets were observed in palmitate-treated cells. The staining of lipid droplets was relatively weaker in CP extracts-treated cells than those treated with palmitate. Therefore, the degree of lipid accumulation within the cell and medium was measured as triglycerides and total cholesterol (TC). As shown in Fig. 3B and 3C , treatment of palmitate significantly increased intracellular triglycerides and TC levels, whereas pretreatment of HepG2 cells with CPWE and CPEE significantly decreased intracellular triglycerides and TC levels, showing a similar pattern between two CP extracts. Furthermore, pre-incubation of HepG2 cells with 100 µg/mL CPWE or CPEE significantly blocked palmitate-induced lipid accumulationfor 24 h (Fig. 3D) . We confirmed accumulation of palmitate-induced triglyceride and TC in HepG2 cell was reduced by the addition of CP extracts. From morphological observation and quantitative analysis, we also found palmitateinduced lipid accumulation in HepG2 cell was decreased time dependently after treatment of cells with CP extracts.
Effects of CP extracts on palmitate-induced production of lipid absorption-related apolipoproteins, apo A1 and B Increased levels of plasma triglyceride and cholesterol are associated with the development of metabolic diseases. Very-low-density lipoprotein (VLDL) secreted from hepatocytes contains a hydrophobic core consisted of TG, cholesterol esters, phospholipids, and apo B. Secretion of VLDL plays a very important role in controlling the plasma levels of TG and cholesterol (23, 24) . Based on the above findings, we examined the effects of CP extracts on palmitateinduced production of lipid absorption-related lipoproteins, apoA1 and B. Figure 4 shows the expression levels of apoA1 and apoB in the lysate and medium. CP extracts significantly decreased palmitateinduced expression level of ApoB in thelysate, but increased ApoB level in the medium. Neither palmitate nor CP extracts altered the expression of ApoA1 in both lysate and medium.
Our present results confirm that CP extracts decreased the secretion of apo B lipoprotein regardless of the intracellular lipogenic state. The synthesis of apo B occurs primarily in hepatic and intestinal cells. When apo B metabolism is used as a nutritional material from the nutritional point of view, it is meaningful to check degradation, assembly, and secretion of VLDL in cultured hepatocytes. The overproduction of apo B-containing lipoproteins has been recognized as a mechanism underlying coronary artery disease and hyperlipidemia (25, 26) .
Effects of CP extracts on palmitate-induced apoptosis in HepG2 cells More recently extensive evidences have been reported that hepatic lipotoxicity is associated with apoptosis (27, 28) . We have demonstrated that CP extracts showed anti-apoptotic effects against palmitate-induced lipoapoptosis in HepG2 cells. The protective effect of CP extracts on palmitate-induced apoptosis was examined using Hoechst 33258 staining. Significant morphological changes in the nuclear chromatin were observed in cells treated with palmitate (Fig.  5A) . The blue emission light was brighter in palmitate-treated cells than control cell. In contrast, nuclei of CP extracts-treated cells showed lesser bright blue staining than palmitate-treated cells. In addition, the cellular DNA fragmentation was observed clearly in HepG2 cells treated with palmitate, while there was no effect in pretreated cells with CP extracts (Fig. 5B) . Therefore, we determined Caspase-3 activity in HepG2 cells treated with palmitate to examine whether there is any anti-apoptotic effect of CP extracts which is mediated through mitochondria-dependent pathway. As a resultant, CP extracts pretreatment significantly reduced palmitate-induced caspase-3 activity (Fig. 5C) .
To investigate the potential mechanism for the protective effects of CP extracts on palmitate-induced apoptosis, the expression of apoptotic proteins was measured by Western blotting. As shown in Fig. 6A , treatment with palmitate remarkably increased Bax expression but decreased Bcl-2 expression, whereas treatment of cells with CP extracts significantly decreased Bax expression but increased Bcl-2 expression. Moreover, the treatment of CP extracts decreased the expressions of cleaved-8, 9 and tBid. The CP extracts also inhibited the release of cytochrome c from the mitochondria into the cytosol (Fig. 6B) .
We first confirmed that palmitate-induced lipoapoptosis was blocked in CP extracts treated HepG2 cell through Hoechst staining and DNA fragmentation. Also, CP extracts inhibited the release of the mitochondrial cytochrome c through regulation of apoptosis-related proteins, Bax and Bcl-2. These findings suggest that CP extracts regulate mitochondrial cell death pathway in palmitate-treated condition. As a resultant, hepatocyte lipotoxicity involves a complex network of proapoptotic stimuli (29) . These results are consistent with recent reports, in which stearic acids, saturated fatty acids, and palmitic in hepatocytes, lead to both time and concentrationdependent lipoapoptosis (6) . These toxic fatty acids stimulate the apoptotic intrinsic pathway, causing to Bax activation, mitochondrial permeabilization, release of cytochrome c, and activation of caspase-3 and 7 (30) .
In conclusion, our findings demonstrated the protective effects of CP extracts on palmitate-induced steatosis via suppression of Apo B protein in HepG2 cells. These results suggest that CP extracts are effective agents for protecting the liver cells against palmitateinduced steatosis and can help to treat fatty liver diseases like NASH.
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